About this trial
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Eligibility criteria
Qualifiers
Mild Cognitive Impairment due to Alzheimer's disease
Dementia with Lewy Bodies
Frontotemporal dementia
Idiopathic normal pressure hydrocephalus (iNPH)
Disqualifiers
History of seizures
Pregnancy
Metal implants in the head (except dental fillings)
Electronic implants (i.e. pace-maker, implanted medical pump)
Trial design
Treatments tested in this trial
- Gamma tACS (40 Hz) over the superior parietal cortex